[Short-acting and depot insulin analogs. Advantages and disadvantages in comparison with current insulin types].
Lehnert
H
H
Klinik für Endokrinologie und Stoffwechselkrankheiten, Universitätsklinikum Magdeburg, Leipziger Strasse 44, 39120 Magdeburg. Hendrik.Lehnert@medizin.Uni-Magdeburg.de
Klose
S
S
Kerner
W
W
D003692:Delayed-Action Preparations; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011247:Pregnancy; D013329:Structure-Activity Relationship; D016896:Treatment Outcome
D003692:Delayed-Action Preparations; D006442:Glycated Hemoglobin; D007328:Insulin